GEN - Genetic Engineering and Biotechnology News9 天
The Sustainability Balance in Bioprocessing
The sustainability of bioprocessing depends on many decisions and technologies. Sustainability and other factors must be in ...
Business Wire11 天
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
announce that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications. 908 Devices remains focused on the growth ...
GEN - Genetic Engineering and Biotechnology News2 天
Celonic Integrates Merck’s Breez Micro-Bioreactor Platform Into Its Process Development ...
The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...
Repligen acquires bioprocessing analytic portfolio from 908 Devices for $70M
Repligen (RGEN) and 908 Devices (MASS) announced that Repligen has purchased 908 Devices’ desktop portfolio of four devices for bioprocessing ...
Repligen deal can expand bioprocessing opportunities, says RBC Capital
After Repligen (RGEN) announced that it has purchased 908 Devices’ (MASS) desktop portfolio of four devices for bioprocessing process ...
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for ...
Amaran Biotech Wins Asia-Pacific Biopharma Excellence Award 2025
Breakthrough Adjuvant AB-801 Secures “Bioprocessing Excellence in Taiwan” HonorTAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE ...
Taiwan News11 天
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
Portfolio includes PAT devices for real-time process monitoring, control and analysis WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq: RGEN), a life sciences ...